Director/PDMR Shareholding
25 September 2010 - 2:15AM
UK Regulatory
TIDMASD
RNS Number : 3102T
Axis-Shield PLC
24 September 2010
Axis-Shield plc
Dundee, Scotland, 24 September 2010. It was today intimated to Axis-Shield plc
(LSE:ASD, OSE:ASD) that Mr Atle Schjøtt, a Persons Discharging Managerial
Responsibilities as described in the Disclosure Rules, has today exercised
options granted to him under the Company's 2007 Sharesave scheme to purchase
4,675 Ordinary shares of 35 pence each at a price of NOK 26.30 per share. This
increases Mr Schjøtt`s beneficial interest from 7,917 Ordinary shares to 12,592
Ordinary shares.
This announcement requires to be made on the London Stock Exchange and is
repeated in Norway for Oslo Stock Exchange purposes in accordance with the
`equivalent information` rule (Rule DTR 2.4).
--Ends--
+-----------------------------------+-----------------------------------+
| For further enquiries please | |
| contact: | |
| Axis-Shield plc | |
+-----------------------------------+-----------------------------------+
| Ian Gilham, Chief Executive | Tel: +44 203 178 7849 |
| Officer | |
| Ronny Hermansen, Finance Director | |
+-----------------------------------+-----------------------------------+
| | |
+-----------------------------------+-----------------------------------+
| M:Communications | |
+-----------------------------------+-----------------------------------+
| Mary-Jane Elliott / Emma Thompson | Tel: +44 207 920 2330 |
| | E-mail: axisshield@mcomgroup.com |
+-----------------------------------+-----------------------------------+
| Geelmuyden Kiese (Norway) | |
+-----------------------------------+-----------------------------------+
| Geir Bjørlo / Håkon Rønning | Tel: +47 48 18 88 00 |
+-----------------------------------+-----------------------------------+
Notes for Editors
About Axis-Shield
Axis-Shield (www.axis-shield.com) is an international in vitro diagnostics
company, headquartered in Dundee with R&D and manufacturing bases in Dundee and
Oslo. The Group specialises in the supply of instruments and tests for the
rapidly growing physician's office testing market and the development,
manufacture and marketing of innovative proprietary diagnostics kits in areas of
clinical need, including cardiovascular and neurological diseases, rheumatoid
arthritis, and diabetes.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUSANRRSAKUAR
Axis-shield (LSE:ASD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Axis-shield (LSE:ASD)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Axis-Shield (London Stock Exchange): 0 recent articles
More Axis-Shield News Articles